SCHEMBL687794

SCHEMBL687794

Cc1ccc([C@H](CC(=O)O)NC(=O)Nc2c(C)ccn(Cc3ccccc3)c2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
ITGB1 P05556 11/20 0.44
ITGA4 P13612 11/20 0.44
LCK P06239 2/20 0.43
POLB P06746 1/20 0.43
CTSA P10619 3/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688110 0.91 MEN1 (0.49) MEN1KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL4698270 0.90 ALDH1A1 (0.44) KDM4EALDH1A1ITGB1ITGA4LCK
SCHEMBL686620 0.90 PTGER3 (0.50) KDM4EALDH1A1ITGB1ITGA4LCK
SCHEMBL687522 0.89 CTSA (0.44) MEN1KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL687381 0.88 CTSA (0.47) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL687486 0.88 ALDH1A1 (0.41) KDM4EALDH1A1ITGB1ITGA4LCK
SCHEMBL687511 0.87 MEN1 (0.46) MEN1KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL686868 0.84 CTSA (0.42) MEN1KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL688357 0.84 POLB (0.41) MEN1KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL687932 0.84 EGLN1 (0.44) MEN1KMT2AKDM4EALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed